A detailed history of Evercore Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Evercore Wealth Management, LLC holds 29,875 shares of BMY stock, worth $1.76 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,875
Previous 39,464 24.3%
Holding current value
$1.76 Million
Previous $1.64 Million 5.62%
% of portfolio
0.02%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $380,299 - $496,230
-9,589 Reduced 24.3%
29,875 $1.55 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $491,492 - $647,060
-12,211 Reduced 23.63%
39,464 $1.64 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $508,012 - $575,987
-10,588 Reduced 17.01%
51,675 $2.8 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $161,389 - $192,582
-3,329 Reduced 5.08%
62,263 $3.19 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $287,944 - $321,967
-4,974 Reduced 7.05%
65,592 $3.81 Million
Q2 2023

Aug 04, 2023

SELL
$63.71 - $70.74 $146,660 - $162,843
-2,302 Reduced 3.16%
70,566 $4.51 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $136,085 - $154,351
-2,071 Reduced 2.76%
72,868 $5.05 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $262,894 - $311,304
3,839 Added 5.4%
74,939 $5.39 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $60 - $35,884
467 Added 0.66%
71,100 $5.05 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $25,780 - $28,392
-355 Reduced 0.5%
70,633 $5.44 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $184,440 - $221,160
-3,000 Reduced 4.05%
70,988 $5.19 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $334,543 - $389,999
-6,238 Reduced 7.78%
73,988 $4.61 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $299,932 - $351,332
-5,069 Reduced 5.94%
80,226 $4.75 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $204,488 - $222,688
-3,303 Reduced 3.73%
85,295 $5.7 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $189,828 - $213,501
-3,199 Reduced 3.48%
88,598 $5.59 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $276,459 - $313,278
-4,788 Reduced 4.96%
91,797 $5.69 Million
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $379,382 - $420,405
-6,606 Reduced 6.4%
96,585 $5.82 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $314,283 - $367,427
5,733 Added 5.88%
103,191 $6.07 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $198,545 - $288,532
-4,279 Reduced 4.21%
97,458 $5.43 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $510,012 - $665,265
10,364 Added 11.34%
101,737 $6.53 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $368,720 - $437,170
-8,621 Reduced 8.62%
91,373 $4.63 Million
Q2 2019

Aug 13, 2019

SELL
$44.62 - $49.34 $133 - $148
-3 Reduced -0.0%
99,994 $4.54 Million
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $259,259 - $309,134
-5,746 Reduced 5.43%
99,997 $4.77 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $278,858 - $361,612
-5,719 Reduced 5.13%
105,743 $5.5 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $480,318 - $541,761
-8,703 Reduced 7.24%
111,462 $6.92 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $373,922 - $466,052
7,400 Added 6.56%
120,165 $6.65 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $245,372 - $282,473
-4,095 Reduced 3.5%
112,765 $7.13 Million
Q4 2017

Feb 13, 2018

SELL
$59.94 - $65.35 $258,940 - $282,312
-4,320 Reduced 3.56%
116,860 $7.16 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $6.69 Million - $7.72 Million
121,180
121,180 $7.72 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Evercore Wealth Management, LLC Portfolio

Follow Evercore Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evercore Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evercore Wealth Management, LLC with notifications on news.